ACT (Commercial & Residential Mortgage Finance) Stock Valuation & Fair Value Significantly overvalued
ACT (Commercial & Residential Mortgage Finance) trades at a blended P/E of 10.2, about 52% above its historical normal valuation, with a forward growth estimate of 4.1% and a PEG of 2.49. Analysts' one-year estimates have been hit 25% of the time.
No quality score is published for this company, which is normal for insurers, banks and REITs. This rating reflects valuation, forecast return and analyst accuracy only. Ratings that cite business quality require one.
Valuation flags
- Overvalued by 52%
- Low growth forecast
Frequently asked questions
Is ACT overvalued?
At a blended P/E of 10.2 versus its historical normal P/E of 6.8, ACT trades about 52% above its typical valuation, with a PEG of 2.49 on 4.1% forward growth. tickerseer currently rates it significantly overvalued.
What is ACT's fair value and PEG?
ACT trades at a blended P/E of 10.2 against a historical normal P/E of 6.8, a PEG of 2.49, and a forward growth estimate of 4.1%.
Has tickerseer's rating of ACT changed?
tickerseer's rating has been significantly overvalued since 2026-07-31.
Industry: Commercial & Residential Mortgage Finance. Create a free account to see the full analysis: the SeerAI score, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in the paid plan.
It's free, and you can unsubscribe any time. Educational content, not investment advice.